Urosphere
PrivateLast Round
Grant
Mar 10, 2015
Company Overview
Urosphere operates in Healthcare & Life Sciences and is based in Toulouse. Its latest recorded funding round was a Grant round in March 2015.
Urosphere is a biotechnology company that provides preclinical research services, including in vivo and in vitro pharmacological assays, for the urogenital, gastrointestinal, and oncological sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Urosphere Comparables
Compare Urosphere with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pelvipharm | 88% | |
| Porsolt | 77% | |
| Humana Biosciences | 75% |
For institutional investors. Book with your work email.
Urosphere Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 10, 2015 | ||||
| Accelerator | Nov 1, 2005 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Urosphere Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Région Occitanie | Grant |
| Nubbo | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 36% MoM, reaching 3.6K.
- May 16, 2026
Monthly visitors grew 351% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Urosphere Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Urosphere's valuation, stock price, and market status.
Is Urosphere a public or private company?
Urosphere is a private company.
What is the current stock price of Urosphere?
Urosphere is a private company, so its shares have no public market price. Caplight tracks Urosphere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Urosphere worth (valuation)?
Valuation information for Urosphere is not publicly available.
Can I buy Urosphere stock?
Urosphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Urosphere's last funding round?
Urosphere's most recent funding round was Grant on March 10, 2015.
Who are the main investors in Urosphere?
Key investors in Urosphere include Eurostars SME programme, Région Occitanie, Nubbo.
Will Urosphere IPO soon?
No public IPO plans have been announced for Urosphere.
How can I track Urosphere secondary market activity?
Caplight tracks bids, offers, and trades in Urosphere's shares on secondary markets.